Alphabet-backed CRM software provider Freshworks floated above its range and now boasts a market cap of $13.5bn.

The IPO price will give the GV-backed restaurant management software provider a market capitalisation of about $20bn at the time of its $870m flotation.

The diabetes management system developer, a spinoff of Sarnoff Corporation, has filed to raise up to $75m in a Nasdaq offering.

Oracle has committed $205m to an initial public offering for the DNA sequencing technology developer with a $410m target for its close.

The Mastercard-backed payment software provider has raised over $1.2bn pre-IPO and has opted to float on the Nasdaq Global Select Market.

The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.

Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.

Foxconn and GoTo Group are contributing to a $250m PIPE deal for the Engie, Panasonic and Sumitomo-backed electric scooter system provider’s reverse takeover.

GV owns a 6.6% stake in the DevOps platform developer, which was valued at $6bn as of a secondary share sale late last year.

Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.